Category Archives: News

The Precision Nutrition Level 2 Certification Master Class: Frequently Asked Questions.

On Wednesday, October 3rd, 2018 we’re opening registration for the Precision Nutrition Level 2 Certification, designed specifically for Level 1 students and graduates who realize that knowing all about the science of nutrition is never enough. Part master class, part grad program, part mentorship, it’s the only course in the world designed to help you… Read More »

The Diabetic Fat Spiral

Free Website Content » Health » Disease Articles So how can anyone be certain about anything? The answer is simple. You can’t be certain. When you encounter someone that tells you they know the answer to life’s questions, absolutely, for certain — RUN! They’re taking the lazy path. They’re not certain — they have just… Read More »

Dental health and Youngsters

What may be more gorgeous than experiencing your child’s vivid smile? The part of health and medicine that relates to the health and medical concerns of newborns and youngsters is Pediatrics as well as the corresponding part of dentistry which is mixed up in analysis and also treatment regarding different conditions of tooth in newborns… Read More »

The Precision Nutrition Level 1 Certification: Frequently Asked Questions.

On Wednesday, October 3rd, 2018, we’re opening registration for the Precision Nutrition Level 1 Certification, the world’s most respected nutrition education program. The Precision Nutrition Certification gives you the knowledge, systems, and tools you need to understand how nutrition influences a person’s health and fitness. Plus the ability to turn that knowledge into a thriving practice.… Read More »

FDA Approves Third of New Migraine Drugs

Sept. 28, 2018 — The FDA has approved the third of a new type of drug to prevent migraine headaches in adults. Galcanezumab-gnlm (Emgality) targets calcitonin gene-related peptide (CGRP), a molecule that’s produced in nerve cells of the brain and spinal cord. The FDA approved two other CGRP drugs for migraine — erenumab (Aimovig) and fremanezumab-vfrm… Read More »